Associated with objective responses (p = 0.0004 and 0.0255, respectively), PFS (p = 0.00079 and 0.0015, respectively), and irAEs (p = 0.0034 and 0.0125, respectively) in anti-PD-1-treated patients with HCC. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.